BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//SAPA-GP - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://sapagp.org
X-WR-CALDESC:Events for SAPA-GP
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230609T210000
DTEND;TZID=America/New_York:20230609T223000
DTSTAMP:20260423T181304
CREATED:20230607T004735Z
LAST-MODIFIED:20230607T004735Z
UID:4531-1686344400-1686349800@sapagp.org
SUMMARY:ASCO2023 Recap: The Winners\, Losers\, and Black Horses
DESCRIPTION:REGISTER HERE
URL:https://sapagp.org/event/asco2023-recap-the-winners-losers-and-black-horses/
LOCATION:PA
CATEGORIES:Event,Webex Meeting
ATTACH;FMTTYPE=image/png:https://sapagp.org/wp-content/uploads/2023/06/ASCO_featured_recap.png
ORGANIZER;CN="SAPA-GP":MAILTO:sapagp@sapa-gp.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230530T210000
DTEND;TZID=America/New_York:20230530T223000
DTSTAMP:20260423T181304
CREATED:20230526T142648Z
LAST-MODIFIED:20230526T142648Z
UID:4495-1685480400-1685485800@sapagp.org
SUMMARY:Preview of ASCO by BioSpark/ISWTC/SAPA-GP
DESCRIPTION:REGISTER HERESpeakersModeratorOrganizers
URL:https://sapagp.org/event/preview-of-asco-by-biospark-iswtc-sapa-gp/
LOCATION:PA
CATEGORIES:Event,Webex Meeting
ATTACH;FMTTYPE=image/png:https://sapagp.org/wp-content/uploads/2023/05/featuered-image.png
ORGANIZER;CN="SAPA-GP":MAILTO:sapagp@sapa-gp.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230517T180000
DTEND;TZID=America/New_York:20230517T203000
DTSTAMP:20260423T181304
CREATED:20230514T002908Z
LAST-MODIFIED:20230514T005959Z
UID:4465-1684346400-1684355400@sapagp.org
SUMMARY:@Philly Company Showcase & Networking Dinner
DESCRIPTION:
URL:https://sapagp.org/event/philly-company-showcase-networking-dinner/
LOCATION:Jin Ding Restaurant\, 1051 Conestoga Rd\, Bryn Mawr\, PA\, 19010\, United States
CATEGORIES:AtPhilly,Career Events,Event,In Person
ATTACH;FMTTYPE=image/jpeg:https://sapagp.org/wp-content/uploads/2023/05/pdf_20230510_095448_0000.jpg
ORGANIZER;CN="SAPA-GP":MAILTO:sapagp@sapa-gp.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230331T120000
DTEND;TZID=America/New_York:20230401T190000
DTSTAMP:20260423T181304
CREATED:20230118T023035Z
LAST-MODIFIED:20230329T122928Z
UID:4163-1680264000-1680375600@sapagp.org
SUMMARY:SAPA-GP 2023 Annual Conference
DESCRIPTION:SAPA-GP 2023 Annual Conference: Embracing New Technologies in a Changing World \nRegister NowAgendaMarch 31st – April 1st\, 2023 (In-Person)\nSheraton Valley Forge Hotel\n480 N Gulph Rd\, King of Prussia\, PA 19406\nClick here to register or scan the QR code on the right.\nDuring the past few years\, the pharmaceutical industry has experienced dramatic changes due to COVID 19 pandemic and technological advancements.  Many of those changes are transforming the industry and speeding up the pace of new drug development. On the technological front\, new drug targets have been discovered at ever increasing speed. AI assisted drug discovery is opening new frontiers. Digital technologies\, decentralized clinical studies\, and real-world evidence are reshaping clinical development. On the business front\, creative business models are weathering the current market downturn and rejuvenating fresh investment\, mergers and acquisitions (M&A)\, and partnership around the world. Regarding patient access\, in responding to skyrocketing price tags of new drugs\, adaptive payment mechanisms have been devised in hope of delivering lifesaving medicines to patients in a sustainable way. \nOn Mar 31st – Apr. 1st\, 2023\, SAPA-GP will hold 2023 annual conference at King of Prussia\, PA. There will be 5 Parallel Tracks: \n\nScientific: Pioneering a New Era of Drug Discovery & Development: Novel Targets\, Innovative Platforms\, and Recent Regulations\nClinical: New Trends in Clinical Development\nBusiness: The Business Engine of New Drug Development: Fundraising\, BD\, and Commercialization\nMarket Research: Promoting Patient Access after Regulatory Approval\nCareer: Career Development\, Diversity\, Labor Law\, and Roundtable Discussion\n\nWe are excited to have Dr. Amir Kalali and Dr. Virginia Man-Yee Lee\, two well-known experts as our keynote speakers\, to share insights from both scientific and clinical perspectives. Moreover\, Dr. Tim Opler will discuss M&A transactions across the pharmaceutical industry\, and Dr. Joga Gobburu will talk about model-informed drug development. \nCheck out our list of top-notch speakers and sponsors: \nRegister NowStay tuned for more speakers and agenda. \nBecoming our Annual Conference sponsors with these benefits:\n• Exhibition booths at the Annual Conference\n• Company showcases in the conference brochure and website\n• Guest speaker slots in parallel sessions\n• A platform for reaching out to potential business partners\n• Far-reaching market penetration via email blasts\, LinkedIn\, and WeChat groups\n• Great opportunities for talent recruitment… and more! For sponsorship opportunities\, please contact: bd@sapa-gp.org \nDo you want to become a Volunteer for SAPA-GP Annual Conference and future events? please contact: sapagp@sapa-gp.org \nRefer to our website for the Refund and Transfer policy and Student Discount. \nSAPA-GP\, supported by the collective wisdom of professionals in the pharmaceutical industry\, strives to shine insight into how the pharmaceutical industry is adapting to the evolving environment and transforming itself into the new era of biopharma 2.0. The SAPA-GP 2023 Annual Conference will be a unique opportunity for people to come together to celebrate the transformation underway\, and more importantly\, to brainstorm how to ride the tide to success. \nCheck out more events on SAPA-GP website or scan the QR code below.
URL:https://sapagp.org/event/sapa-gp-2023-annual-conference/
LOCATION:Sheraton Valley Forge Hotel\, 480 North Gulph Road\, King of Prussia\, PA\, 19406\, United States
CATEGORIES:AC,Event,In Person
ATTACH;FMTTYPE=image/jpeg:https://sapagp.org/wp-content/uploads/2023/01/banner.jpg
ORGANIZER;CN="SAPA-GP":MAILTO:sapagp@sapa-gp.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230126T200000
DTEND;TZID=America/New_York:20230126T213000
DTSTAMP:20260423T181304
CREATED:20230119T131125Z
LAST-MODIFIED:20230120T033331Z
UID:4225-1674763200-1674768600@sapagp.org
SUMMARY:Humanized mouse models to accelerate drug development - SAPA-GP Webinar Jan 26\, 2023
DESCRIPTION:Register HereSanti s. ChenAssociate Director\, Immunology and Oncology\, GemPharmatechSanti is a research scientist and business development professional with over 10 years of experience in autoimmune disease\, immunology\, and oncology disease areas. Santi received her training in human B cell development at the Garvan Institute of Medical Research Australia in Immunology\, followed by a postdoctoral fellowship at the Children’s Cancer Institute Australia\, focusing on pediatric leukemia and therapies. Her projects include testing agents’ efficacy and mechanisms such as navitoclax\, venetoclax\, and selumetinib. Her research projects resulted in multiple publications in journals such as Blood and Journal of Immunology and national/international awards.Sponsored by GemPharmatechGemPharmatech\, a leading provider of mouse models and preclinical services\, offers a one-stop solution for in vivo studies with a collection of more than 20\,000 strains including KO/cKO\, humanized\, disease\, germ-free and custom models\, as well as custom breeding services. \nSponsored by GemPharmatech; Contact: sales@gempharmatech.us
URL:https://sapagp.org/event/4225/
LOCATION:PA
CATEGORIES:Event,Webex Meeting
ATTACH;FMTTYPE=image/png:https://sapagp.org/wp-content/uploads/2023/01/Featured-pic.png
ORGANIZER;CN="SAPA-GP":MAILTO:sapagp@sapa-gp.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20221209T090000
DTEND;TZID=America/New_York:20221209T153000
DTSTAMP:20260423T181304
CREATED:20221201T171457Z
LAST-MODIFIED:20221201T173243Z
UID:4104-1670576400-1670599800@sapagp.org
SUMMARY:SAPA-GP Career Development Workshop
DESCRIPTION:Ignite Your Career GrowthWhat are your career goals for 2023? \n\nGet promoted?\nChange to a different role?\nBe more effective in your current role?\nMove from a technical to business role?\n\nIf so\, this Career Development Workshop is for YOU! \nCome learn and build your network \nREGISTER HERE!FEATURED SPEAKERSDavid CraginSenior Director\, Product ScienceTeva PharmaceuticalsCheryl PaesVP\, Head of MarketingCenter for Breakthrough MedicinesJing YangCo-founder & Board DirectorBaseCure TherapeuticsJamie HuangFounderPrinceton Leadership AcademyJoe LingleChief People OfficerCenter for Breakthrough MedicinesPan PanDirector of Business DevelopmentAkeso\, Inc.Audrey GreenbergCo-Founder & Chief Business OfficerCenter for Breakthrough MedicinesAgenda8:30am – 9:00am \n9:00am – 9:30am \nRegistration \nOpening remark & Keys to On-line and In-person networking \nDavid Cragin \nSenior Director\, Product Science \nTeva Pharmaceuticals \n9:30am – 10:00am \nTopic 1: The secrets of HR \nJoe Lingle \nChief People Officer \nCenter for Breakthrough Medicines \n10:00am – 10:30am \n1030am – 11:00am \nNetworking Break I \nTopic 2: Take a Chance on Unexpected Opportunities \nJing Yang \nCo-founder & Board Director \nBaseCure Therapeutics \n11:00am – 11:30am \nPanel Discussion \nAudrey Greenberg \nCo-Founder and Chief Business Officer \nCenter for Breakthrough Medicines \nJing Yang \nCo-founder & Board Director \nBaseCure Therapeutics \n11:30am – 1:00pm \n1:00pm – 1:40pm \nLunch Break \nTopic 3: Getting off the Sticky Floor \nJamie Huang \nFounder \nPrinceton Leadership Academy \n1:40pm – 2:00pm \n2:00pm – 2:40pm \nNetworking Break II \nTopic 4: A Path from R&D to Business Development \nPan Pan \nDirector of Business Dvelopment \nAkeso\, Inc \n2:40pm – 3:10pm \nPanel Discussion \nCheryl Paes \nVP\, Head of Marketing \nCenter for Breakthrough Medicines \nPan Pan \nDirector of Business Development \nAkeso\, Inc. \nScan QR code for registration\, or follow this registration link: \nhttps://www.eventbrite.com/e/sapa-gp-2022-career-development-workshop-igniting-your-career-growth-tickets-467770322627
URL:https://sapagp.org/event/sapa-gp-career-development-workshop/
LOCATION:The Center for Breakthrough Medicines\, 411 Swedeland Road\, #100\, King of Prussia\, PA\, 19406\, United States
CATEGORIES:Career Events,Event,In Person,Webex Meeting
ATTACH;FMTTYPE=image/png:https://sapagp.org/wp-content/uploads/2022/12/featured.png
ORGANIZER;CN="SAPA-GP":MAILTO:sapagp@sapa-gp.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20221110T200000
DTEND;TZID=America/New_York:20221110T213000
DTSTAMP:20260423T181304
CREATED:20221104T222406Z
LAST-MODIFIED:20221105T122416Z
UID:4080-1668110400-1668115800@sapagp.org
SUMMARY:Mouse Models for Disease Mechanism Studies and Drug R&D
DESCRIPTION:Register HereXiang Gao\, Ph.D.Founder and Chairman of GemPharmatechXiang Gao is an alumina of Nanjing University. He received his Ph.D. degree from Thomas Jefferson University in 1994\, then did his postdoctoral training at the Jackson Lab. In 2000\, Xiang was recruited back as professor at Nanjing University. Where he founded both Model Animal Research Center of NJU and National Resource Center of Mutant Mice of China. He was the associate dean of Medical School and director for the State Key Laboratory of Pharmaceutical Biotechnology. Xiang is the recipient for Cheung Kong Scholar from Ministry of Education and Distinguished Young Scholar from National Science Foundation. His lab has been focused on understanding the physiological homeostasis of metabolic and immunological processes. He has been funded by multiple national grants and published more than 200 research papers. Xiang is recipient of many national and international awards\, including the National Science and Technology Progress Award. In 2017\, Xiang founded GemPharmatech (GPT) which has become the leading company for animal model generation and application. GPT is the largest mutant mouse resource center in the world and now holds more than 22\,000 mutant mouse strains. GPT went IPO early this year at STAR market in Shanghai Exchange.Sponsored by: GemPharmatech\nGemPharmatech\, a leading provider of mouse models and preclinical services. With a collection of 20\,000+ strains\, GPT offers KO/cKO\, humanized\, disease\, and custom models\, as well as a one-stop solution for in vivo studies. Contact: brook.white@gempharmatech.us
URL:https://sapagp.org/event/mouse-models-for-disease-mechanism-studies-and-drug-rd/
LOCATION:PA
CATEGORIES:Event,Webex Meeting
ATTACH;FMTTYPE=image/jpeg:https://sapagp.org/wp-content/uploads/2022/11/Nov.-10-Webinar-feature.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220915T200000
DTEND;TZID=America/New_York:20220915T213000
DTSTAMP:20260423T181304
CREATED:20220910T144808Z
LAST-MODIFIED:20220911T223208Z
UID:3944-1663272000-1663277400@sapagp.org
SUMMARY:Accelerating Cell & Gene Therapy Innovations: NK Cell Therapy\, Preclinical Solutions\, and CRO
DESCRIPTION:Register HereDongfang LiuAssociate Professor/Director of Immunoassay Development ProgramDongfang Liu\, Ph.D.\, an Associate Professor and Director of Immunoassay Development Program at the Department of Pathology\, Immunology and Laboratory Medicine in Rutgers University- New Jersey Medical School. In 2012\, Dr. Liu was recruited to Baylor College of Medicine as a tenure-track Assistant Professor in the Department of Pediatrics\, and Pathology & Immunology\, before joining Houston Methodist Research Institute (HMRI) as an Assistant Professor in 2015. In 2018\, Dr. Liu was promoted to an Associate Professor in HMRI. Dr. Liu did his Ph.D. and postdoctoral training on natural killer (NK) cells. After completing the postdoctoral training\, he joined Ragon Institute of MGH\, MIT and Harvard in 2011 as a senior research scientist\, where he worked on HIV-specific immune cell dysfunction. Dr. Liu’s research is primarily focused on the immunobiology of NK and chimeric antigen receptor (CAR)-NK cells. He has more than 20 years’ experience in NK cell research. Dr. Liu has published research papers in top-tier journals\, including Nature Immunology\, Immunity\, Nature Communications\, JACI\, Proc. Natl. Acad. Sci.\, and others. Dr. Liu serves on several editorial boards for multiple journals and as a reviewer for a number of journals and several grant agencies.Santi ChenAssociate Director\, Immunology and Oncology\, GemPharmatechSanti is a research scientist and business development professional with over 10 years of experience in autoimmune disease\, immunology\, and oncology disease areas. Santi received her training in human B cell development at the Garvan Institute of Medical Research Australia in Immunology\, followed by a postdoctoral fellowship at the Children’s Cancer Institute Australia\, focusing on pediatric leukemia and therapies. Her projects include testing agents’ efficacy and mechanisms such as navitoclax\, venetoclax\, and selumetinib. Her research projects resulted in multiple publications in journals such as Blood and Journal of Immunology and national/international awards. \nSponsored by GemPharmatechGemPharmatech\, a leading provider of mouse models and preclinical services. With a collection of 21\,000 strains\, GPT offers KO/cKO\, humanized\, disease\, and custom models\, as well as a one-stop solution for in vivo studies. \nContact: keila.woods@gempharmatech.us
URL:https://sapagp.org/event/accelerating-cell-gene-therapy-innovations-nk-cell-therapy-preclinical-solutions-and-cro/
LOCATION:PA
CATEGORIES:Event,Webex Meeting
ATTACH;FMTTYPE=image/png:https://sapagp.org/wp-content/uploads/2022/09/Flyer-Sept-15_feature.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20220617
DTEND;VALUE=DATE:20220619
DTSTAMP:20260423T181304
CREATED:20220428T020820Z
LAST-MODIFIED:20220911T023723Z
UID:3688-1655424000-1655596799@sapagp.org
SUMMARY:@Philly Cell & Gene Therapy Annual Conference 2022
DESCRIPTION:
URL:https://sapagp.org/event/philly-cell-gene-therapy-annual-conference-2022/
LOCATION:Sheraton Valley Forge Hotel\, 480 North Gulph Road\, King of Prussia\, PA\, 19406\, United States
CATEGORIES:AtPhilly,Event,In Person
ATTACH;FMTTYPE=image/png:https://sapagp.org/wp-content/uploads/2022/04/Screen-Shot-2022-04-16-at-08.29.05.png
ORGANIZER;CN="SAPA-GP":MAILTO:sapagp@sapa-gp.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220524T200000
DTEND;TZID=America/New_York:20220524T213000
DTSTAMP:20260423T181304
CREATED:20220511T191641Z
LAST-MODIFIED:20220911T022309Z
UID:3816-1653422400-1653427800@sapagp.org
SUMMARY:Finding your Pathway to Success - Career meeting
DESCRIPTION:Register Here
URL:https://sapagp.org/event/finding-your-pathway-to-success-career-meeting/
LOCATION:PA
CATEGORIES:Career Events,Event,Webex Meeting
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20220415T120000
DTEND;TZID=America/New_York:20220416T190000
DTSTAMP:20260423T181304
CREATED:20220314T012254Z
LAST-MODIFIED:20220911T023850Z
UID:3622-1650024000-1650135600@sapagp.org
SUMMARY:Turbo Charging Innovation in the New Decade of Life Sciences --- US-China Biopharma Congress - SAPA-GP 2022 Annual Conference (Hybrid)
DESCRIPTION:Turbo Charging Innovation in the New Decade of Life Sciences  Sheraton Valley Forge Hotel\n480 N Gulph Rd\, King of Prussia\, PA 19406\nor\nthrough Online Platform and Mobile App \nRegister Here中国地区平台注册AgendaProgram Brochure As the flagship event of SAPA-GP\, our Annual Conference attracted over 1\,000 attendees each year\, featuring presentations and panel discussions by distinguished speakers and panelists from academia\, industry\, and regulatory authorities\, to provide opportunities for scientific exchange\, public health education\, networking\, career development\, and business collaborations. After two years of postponement due to the pandemic situation\, we have decided that it is time to host the annual conference again\, through a hybrid platform\, which allows for both local participants to enjoy the social networking again\, and global participants to connect from all over the world without geographic restrictions. You can join us from Anywhere!\n\n1 week final count down! Register now or onsite. \n3 Parallel Tracks:\n\nScientific track: Redefining pharmaceutical innovation from bench to bedside\nBusiness track: Unleashing the power from scientific breakthroughs and entrepreneurship (Co-branding with BioKatalyst)\nCareer track: Preparing life scientists for the future\n\n\nAgenda and Speakers Highlights below:\n\nFor detailed Agenda\, please check here or click on the Agenda Tab.\n\nEnjoy the benefits of Hybrid Platform: \nOnline: \n\n\nAccess to mobile app for program navigation and live stream of all presentations.\nSchedule 1-1 meetings with all attendees including sponsors through mobile app and online platform.\nRandom matchmaking and speed networking\n1 month access to cloud recording of presentation videos\n\nOnsite:\n\nAll benefits from online\nFood & beverage included (worth $80/person)\nFriday: Snack Bar (4-5pm)\, free coffee\nSaturday: Lunch box (11:30 am-12:30pm) & Snack Bar (4-5pm)\, free coffee\nAttend company show cases and opportunities of direct contact/mock interview with hiring manager from 10+ prestigious pharmaceutical companies.\nSocial networking with speakers and other attendees from pharmaceutical industry\nAttend career development workshops and join 1-1 SAPA-GP mentoring program\n\nSponsors
URL:https://sapagp.org/event/turbo-charging-innovation-in-the-new-decade-of-life-sciences-us-china-biopharma-congress-sapa-gp-2022-annual-conference-hybrid/
LOCATION:Sheraton Valley Forge Hotel\, 480 North Gulph Road\, King of Prussia\, PA\, 19406\, United States
CATEGORIES:AC,Event
ATTACH;FMTTYPE=image/jpeg:https://sapagp.org/wp-content/uploads/2022/03/AC2022.jpg
ORGANIZER;CN="SAPA-GP":MAILTO:sapagp@sapa-gp.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210715T200000
DTEND;TZID=America/New_York:20210715T213000
DTSTAMP:20260423T181304
CREATED:20210702T001923Z
LAST-MODIFIED:20221201T192628Z
UID:3502-1626379200-1626384600@sapagp.org
SUMMARY:Cell & Gene Therapy (CGT) Rapid Growth in China: What Could be Your Share of the Pie?
DESCRIPTION:Register HereSpeakers:Amit AgarwalManaging Director\, Life Sciences San Francisco\, CA Amit is a Managing Director in Deloitte Consulting’s Life Sciences practice. Amit has more than 25 years of management consulting experience and has led multiple projects in both strategy and operations Amit co-leads the Next Generation Therapies practice. The practice focuses on advising clients on taking advantage of and/or developing strategic responses to new disruptive technologies in cell and gene therapies space. Amit has worked with Life Science clients in the U.S. Europe and Asia on high-impact projects.\nAmit also has experience as Vice President at Leerink Swann & Co.\, a boutique investment bank focused on the life sciences. He helped innovative life science companies raise capital\, identify merger and acquisition targets and negotiate strategic partnerships and alliances. He helped his clients generate nearly $1 billion of market value through the deals he helped broker.\nAmit publishes extensively in the business press and in peer reviewed academic journals on personalized medicine. Amit has presented at multiple conferences in North America\, South America and Europe and worked with industry associations on value-based care and risk sharing contracts in light of new technology paradigms.\nAmit holds an MBA in finance and technological innovation from the MIT Sloan School of Management and a bachelor’s degree in history and premed from Occidental College. Prior to business school\, Amit conducted research in neurobiology at the California Institute ofTechnology and was an American diplomat posted in China and the Middle East. Annie XuSpecialist Leader\, Life Sciences and Health Care\, Deloitte Consulting\, USAI am a core member of Deloitte’s NextGen Practice\, with a focus on helping cell and gene companies set up their supply chain and commercial platform to launch their products globally. I co-lead Deloitte’s Industry Working Group (IWG)\, working closely with industry leaders to design patient-centric solutions that provide CGT access to a broader patient population.\nRelevant experiences:\n1. Developed a digital strategy to support the first gene-editing product launch in the US and EMEA\n2. Performed the market landscape assessment for cell and gene therapies and developed the investment strategy for a PE firm\n3. Led patient journey development and market sizing for an ultra-rare disease gene therapy\, and develop launch strategy in Saudi\, Russia\, Japan\, and Brazil\nSupported commercial site certification across 80+ hospitals within the US for a CAR-T product\n4. Drove the global launch readiness for the most expensive gene therapy product outside of the US\, with a projected $1B sales revenue in 2020David Xie\, PhDPartner\, NextGen expertI’m a Partner based in Shanghai\, China with a focus on biotech and next generation therapies practice. We often take a China specific view and help clients to understand the intricate and fast-evolving policies environment and what it means for entry strategy\, regulatory path\, market access\, and go-to-market models. We also tackle next-generation specific issues such as site certification and supply chain visibility. My experience in CGT:\n1. Led multiple projects with leading overseas biopharma companies to help define China product regulatory paths\, market access and GTMs including CAR-T\, targeted oncology drugs\, and rare disease drugs\n2. Worked on global supply chain and China commercial excellence to define China entry and supply chain models for Cell & Gene Therapies\n3. Worked on the launch of multiple CAR-T products access and pricing strategy in China\n4. Worked on the companion genetic diagnosis tests clinical development and GTM assessment as part of the CGT product portfolio\n5. Represent the Deloitte Next Generation Therapies practice in China with thought leadership on driving In China For China business modelsJohn Law Strategy and Business Design Manager\, Deloitte Consulting\, ChinaJohn is a Shanghai based Manager at the Strategy & Business Design service\nline\, also known as Monitor Deloitte and now part of Strategy\, Analytics and M&A offering portfolio\, of Deloitte Consulting. He studied Biomedical Sciences at University of Oxford where he specialized in scientific data analysis as well as experimental testing; through which he developed a research oriented and data driven approach to solving problems.\nJohn possesses a diverse skill set from strategy to operations in Life Sciences\nand Health Care consulting. His strong written and verbal communication skills also contributed to his successful track record in interacting with clients across levels. John is fluent in English\, Mandarin Chinese and Cantonese Chinese.\nSelected project experience:\n• Assessed China competitive landscape as well as pricing and reimbursement environment for a leading British multinational pharmaco’s hepatocellular carcinoma CAR T; designed likely market access journey for client’s CAR T by formulating various reimbursement scenarios and price volume relationship\n• Evaluated China go to market model options for a leading Japanese multinational pharmco’s portfolio of gene therapies having identified relevant regulatory barriers; designed entry roadmap from entity set up\, clinical trials\, product and materials import to commercialization\n• Estimated China market size and attractiveness for a leading Japanese multinational medical device company’s cell processing center; identified use cases and customer segments and developed unique value propositions\nJohn holds a Master and a Bachelor degree in Biomedical Sciences from University of Oxford.
URL:https://sapagp.org/event/cell-gene-therapy-cgt-rapid-growth-in-china-what-could-be-your-share-of-the-pie/
LOCATION:PA
CATEGORIES:Event,Webex Meeting
ATTACH;FMTTYPE=image/png:https://sapagp.org/wp-content/uploads/2021/07/July-15-Webinar-e1625185124573.png
ORGANIZER;CN="SAPA-GP":MAILTO:sapagp@sapa-gp.org
END:VEVENT
END:VCALENDAR